A detailed history of Cape Ann Savings Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Cape Ann Savings Bank holds 2,453 shares of ABT stock, worth $287,638. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,453
Previous 2,288 7.21%
Holding current value
$287,638
Previous $237,000 17.72%
% of portfolio
0.16%
Previous 0.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$100.07 - $118.13 $16,511 - $19,491
165 Added 7.21%
2,453 $279,000
Q2 2024

Jul 25, 2024

SELL
$100.73 - $112.44 $6,043 - $6,746
-60 Reduced 2.56%
2,288 $237,000
Q4 2023

Mar 15, 2024

SELL
$90.19 - $110.4 $6,764 - $8,280
-75 Reduced 3.1%
2,348 $258,000
Q3 2023

Oct 25, 2023

SELL
$95.53 - $114.62 $17,673 - $21,204
-185 Reduced 7.09%
2,423 $234,000
Q2 2023

Sep 18, 2023

BUY
$100.78 - $112.29 $262,834 - $292,852
2,608 New
2,608 $284,000
Q1 2023

Sep 18, 2023

SELL
$96.86 - $114.01 $259,972 - $306,002
-2,684 Closed
0 $0
Q2 2022

Aug 24, 2022

SELL
$102.07 - $123.37 $15,310 - $18,505
-150 Reduced 5.29%
2,684 $292,000
Q1 2022

May 18, 2022

SELL
$114.02 - $139.04 $376,722 - $459,388
-3,304 Reduced 53.83%
2,834 $335,000
Q4 2021

Feb 16, 2022

SELL
$115.53 - $141.46 $36,045 - $44,135
-312 Reduced 4.84%
6,138 $864,000
Q3 2021

Nov 22, 2021

SELL
$116.66 - $129.06 $17,615 - $19,488
-151 Reduced 2.29%
6,450 $762,000
Q2 2021

Aug 17, 2021

SELL
$105.79 - $124.53 $9,732 - $11,456
-92 Reduced 1.37%
6,601 $765,000
Q1 2021

May 25, 2021

SELL
$108.84 - $128.23 $37,223 - $43,854
-342 Reduced 4.86%
6,693 $802,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $159,075 - $173,346
-1,515 Reduced 17.72%
7,035 $770,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $30,704 - $39,298
-401 Reduced 4.48%
8,550 $782,000
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $20,460 - $22,185
-250 Reduced 2.72%
8,951 $749,000
Q2 2019

Jul 31, 2019

SELL
$72.88 - $85.0 $54,660 - $63,750
-750 Reduced 7.54%
9,201 $773,000
Q1 2019

May 06, 2019

SELL
$66.22 - $80.06 $52,446 - $63,407
-792 Reduced 7.37%
9,951 $795,000
Q4 2018

Feb 15, 2019

SELL
$65.56 - $74.27 $47,727 - $54,068
-728 Reduced 6.35%
10,743 $777,000
Q3 2018

Oct 23, 2018

SELL
$60.81 - $73.36 $1,277 - $1,540
-21 Reduced 0.18%
11,471 $842,000
Q3 2018

Oct 22, 2018

BUY
$60.81 - $73.36 $698,828 - $843,053
11,492 New
11,492 $733,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cape Ann Savings Bank Portfolio

Follow Cape Ann Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Ann Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cape Ann Savings Bank with notifications on news.